Abstract
Age-related impairment of central functions is though to result from alterations of neurochemical indices of synaptic function. These neurochemical modifications involve structural proteins, neurotransmitters, neuropeptides and related receptors. Several studies demonstrated that GABA receptors, glutamic acid decarboxylase (GAD65&67), and different subpopulations of GABAergic neurons are markedly decreased in experimental animal brains during aging. Thus, the age-related decline in cognitive functions could be attributable, at least in part, to decrements in the function of the GABAergic inhibitory neurotransmitter system. In this study we show that chronic supplementation of taurine to aged mice significantly ameliorated the age-dependent decline in memory acquisition and retention, and caused alterations in the GABAergic system. These changes include increased levels of the neurotransmitters GABA and glutamate, increased expression of glutamic acid decarboxylase and the neuropeptide somatostatin and increased in the number of somatostatin-positive neurons. These specific alterations of the inhibitory system caused by taurine treatment oppose those naturally-occurring during aging, and suggest a protective role of taurine in this process.
Increased understanding of age-related neurochemical changes in the GABAergic system will be important in elucidating the underpinnings of the functional changes of aging. Taurine might help forestall the age-related decline in cognitive functions through interaction with the GABAergic system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Araki T, Kato H, Fujiwara T, Itoyama Y (1996) Regional age-related alterations in cholinergic and GABAergic receptors in the rat brain. Mech Ageing Dev 88:49–60
Aruoma O I, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256:251–255
Banay-Schwartz M, Lajtha A, Palkovits M (1989) Changes with aging in the levels of amino acids in rat CNS structural elements II Taurine and small neutral amino acids. Neurochem Res 14:563–570
Banay-Schwartz M, Lajtha A, Palkovits M (1989) Changes with aging in the levels of amino acids in rat CNS structural elements I Glutamate and related amino acids. Neurochem Res 14:555–562
Caspary DM, Raza A, Lawhorn Armour BA, Pippin J, Arnerić SP (1990) Immunocytochemical and neurochemical evidence for age-related loss of GABA in the inferior colliculus: implications for neural presbycusis. J Neurosci 10(7):2363-72.
Caspary DM, Milbrandt JC, Helfert RH (1995) Central auditory aging: GABA changes in the inferior colliculus. Exp Gerontol 30:349–360
Caspary DM, Palombi PS, Hughes LF (2002) GABAergic inputs shape responses to amplitude modulated stimuli in the inferior colliculus. Hear Res 168:163–173
Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer’s disease and Alzheimer senile dementia Nature 288:279–280
del Olmo N, Bustamante J, del Rio RM, Soli J (2000) Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res 864:298–307
Dournaud P, Jazat-Poindessous F, Slama A, Lamour Y, Epelbaum J (1996) Correlations between water maze performance and cortical somatostatin mRNA and high-affinity binding sites during ageing in rats Eur J Neurosci 8:476–485
El Idrissi A, Messing J, Scalia J, Trenkner E (2003) Prevention of Epileptic Seizures through taurine. In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine 5 Beginning the 21st Century, Adv Exp Med Biol, Vol 526, Kluwer Press, NewYork, pp 515–525
El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189–197
El Idrissi A, Trenkner E (1999) Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19:9459–9468
Govoni S, Memo M, Saiani L, Spano PF, Trabucchi M (1980) Impairment of brain neurotransmitter receptors in aged rats. Mech Ageing Dev 12:39–46
Gutiérrez A, Khan ZU, Morris SJ, De Blas AL (1994) Age-related decrease of GABAA receptor subunits and glutamic acid decarboxylase in the rat inferior colliculus. J Neurosci 14: 7469–7477
Häusser MA, Yung WH, Lacey MG (1992) Taurine and glycine activate the same Cl- conductance in substantia nigra dopamine neurons. Brain Res 571:103–108
Hunter C, Chung E, Van Woert MH (1989) Age-dependent changes in brain glycine concentration and strychnine-induced seizures in the rat. Brain Res 482:247–251
Huxtable RJ (1989) Taurine in the central nervous system and the mammalian action actions of taurine. Prog Neurobiol 32:471–533
Huxtable RJ (1992) The physiological actions of taurine. Physiol Rev 72:101–163
Kuriyama K, and Hashimoto T (1998) Interrelationship between taurine and GABA. Adv Exp Med Biol 442:329–337
Kuwahara S, Kesuma Sari D, Tsukamoto Y, Tanaka S, Sasaki F (2004) Age-related changes in growth hormone (GH)-releasing hormone and somatostatin neurons in the hypothalamus and in GH cells in the anterior pituitary of female mice. Brain Res 1025:113–122
Levinskaya N, Trenkner E, El Idrissi A (2006) Increased GAD-positive neurons in the cortex of taurine-fed mice. Adv Exp Med Biol 583:411–417
Marczynski TJ (1998) GABAergic deafferentation hypothesis of brain aging and Alzheimer’s disease revisited. Brain Res Bull 45:341–379
Mellor JR, Gunthorpe MJ, and Randall AD (2000) The taurine uptake inhibitor guanidinoethyl sulphonate is an agonist at gamma-aminobutyric acid(A) receptors in cultured murine cerebellar granule cells. Neurosci Lett 286:25–28
Milbrandt JC, Albin RL, Turgeon SM, Caspary DM (1996) GABAA receptor binding in the aging rat inferior colliculus. Neuroscience 73:449–458
Quinn MR, and Harris CL (1995) Tautine allosterically inhibits binding of [35S]-t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes. Neuropharmacol 34:1607–1613
Raza A, Milbrandt JC, Arneric SP, Caspary DM (1994) Age-related changes in brainstem auditory neurotransmitters: measures of GABA and acetylcholine function. Hear Res 77:221–230
Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Nenrosci Lett 20:373–377
Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, Suemoto T, Higuchi M, Saido TC (2005) Somatostatin regulates brain amyloid beta peptide, beta42 through modulation of proteolytic degradation. Nat Med 11:434–439
Sturman JA (1993) Taurine in development. Physiol Rev 73:119–147
Wang DS, Xu TL, Pang ZP, Li JS, Akaike N (1998) Taurine-activated chloride currents in the rat sacral dorsal commissural neurons. Brain Res 792:41–47
Wu JY, Tang XW, Schloss JV, Faiman MD (1998) Regulation of taurine biosynthesis and its physiological significance in the brain. Adv Exp Med Biol 442:339–345
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Idrissi, A.E., Boukarrou, L., Splavnyk, K., Zavyalova, E., Meehan, E.F., L’Amoreaux, W. (2009). Functional Implication of Taurine in Aging. In: Azuma, J., Schaffer, S.W., Ito, T. (eds) Taurine 7. Advances in Experimental Medicine and Biology, vol 643. Springer, New York, NY. https://doi.org/10.1007/978-0-387-75681-3_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-75681-3_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-75680-6
Online ISBN: 978-0-387-75681-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)